• Intellectual Property
• Information Technology
• Pharmaceuticals/Health Care/Regulatory

Intellectual Property

• Administrative and Technical Updates at the Canadian Intellectual Property Office (PDF Format)
• Federal Court of Canada Re-examines Test of Obviousness in Patent law (PDF Format)
• CIPO Releases Updated Industrial Design Office Practices
• Next Steps: The Aftermath Following the Dismissal by the Federal Court of Canada of CRIA’s Motion For Disclosure In File Sharing Suits
• Supreme Court of Canada Begins Hearing Arguments On Tariff 22
• The Federal Court of Appeal Ruled on Issue of Distinctiveness in Boston Pizza International Inc. v. Boston Chicken Inc.
• How Much is my Million-Dollar Idea Actually Worth?
• The Supreme Court of Canada Finds Higher Life Forms Not Patentable Subject Matter
• Inventorship, Authorship, Ownership: Employees and Patent/Copyright
• Patents and Standard-Setting: Hot Issues for Patent Owners
• The Boilerplate: What Does it Accomplish?
• The Madrid Protocol: When Will this European Fashion Arrive in North America and How Does it Suit You?
• Competition Bureau Releases Intellectual Property Enforcement Guidelines
• Official Marks
• Triangular Chocolate Bars Confusing
• Cultural Objections over U.S. Life-Form Patents
• Agreements with Contractors and Employees
• Obscure Intellectual Property Rights
• Using Trademarks and Copyright to Protect Your Property
• Patent, Trade Secret, and Technology Licensing and Joint Ventures: A Few Practical Issues
• Representations & Warranties
• Purchase and Sale of a Business: Protecting and Transferring Intellectual Property and Technology Assets

Information Technology

• Case Comment: BSkyb Ltd & Anor v HP Enterprise Services UK Ltd & Anor (Rev 1)
• IP in Outsourcing: What’s Mine is Mine; What’s Yours is …?
• Developments in Micropayment Systems
• Outsourcing in a Global Village
• Outsourcing and Other Cross-Border Data Transfers (PDF Format)
• Identity Theft in Canadian Criminal and Regulatory Statutes (PDF Format)
• Prognosticating Privacy Protection (PDF Format)
• Privacy Commissioner gives Green Light to Cross-Border Outsourcing of Personal Information; Raises Question (PDF Format)
• DNA Samples – Make Believe Privacy in a Technological World – Case Comment R. v. Rodgers (PDF Format)
• Living Rooms are not Public Spaces – Case Comment R. v. Clark (PDF Format)
• BC Drafts New Rules on International Outsourcing of Personal Information (PDF Format)
• Lawful Access – Cybercrime and Punishment (PDF Format)
• Online Privacy Laws: Lessons From the Canadian Pharmaceutical Industry (PDF Format)
• BC Attempts to Regulate International Outsourcing of Personal Information
• Public Consultation Leads to Revised Draft Regulation Under Ontario’s Consumer Protection Legislation
• The Pickwick (Privacy) Papers: A Case Comment on Rodgers v. Calvert and the meaning of "commercial activity" under the Personal Information Protection and Electronic Documents Act
• Setting the Threshold for the Admissibility of Computer Generated Evidence – A Brief Review of Recent US and Canadian Decisions
• Does Your Insurance Policy Cover You? – The Question of Computer Data as "Tangible" or "Intangible" Property Under Insurance Law
• International Anti-Spam Update II
• International Anti-Spam Update
• Online Business in Canada
• Privacy Matters – PIPEDA
• Avoiding Project Chaos
• Before You Outsource
• Employees and Email
• Internet Sales Contracts
• Content Licensing Principles
• Eleven Famous Lines in System Acquisition
• Posting Electronic Signatures on Parcel Tracking Web Site Violates Canadian Privacy Law
• Developments in Information Technology Law
• Everything You Wanted to know about Domain Name Purchase Agreements
• Federal Government to Levy Blank CD-Rewritable Media
• Online Contracts Enforceable in Canada
• WIPO Tackles Domain Name and Trademark Conflicts
• Internet Domain Name Cases
• Canada Announces Cryptography Policy and Employment Contracts
• Dispute Resolution and Arbitration for Electronic Commerce
• On-line Contracts: Electronic Creation of Effective Contracts

Pharmaceuticals/Health Care/Regulatory

• Caffeine in Foods and the Changing Regulatory Landscape
• Recent Section 8 Damages Decisions of the Federal Court of Canada
• Supreme Court of Canada Clarifies How Access-To-Information Applies to Pharmaceutical Cases
• Law and Regulatory: Synergy and Conflict
• Natural Health Products – Big Changes Coming Fall 2010
• Major Changes Proposed for Ontario’s Drug Benefits System
• Downward Pressures on Generic Drug Costs Heighten
• The Canadian Special Access Program
• Moving a US Botanical Product into Canada
• Federal Court Invalidates Olanzapine Patent: Evidentiary Requirements to Establish an Advantage on Which Selection is Based
• Federal Court of Appeal Rules That Improper Selection Not an Independent Ground of Invalidity
• Proposed Legislation for the Regulation of Food, Health and Consumer Products in Canada
• Global Harmonization of Medical Devices in Canada
• Drug, Food and Device Regulation in Canada 2008: The Year in Review
• Canadian and European Governments Call for Increased Competition in the Pharmaceutical Sector
• Recent Deals Signal a Continued Shift in the Innovative Pharmaceutical Business Model
• Amendments to NOC Regulations Come into Force
• Changes to Schedule “A” to Canada’s Food and Drugs Act Come Into Force June 1, 2008 (PDF Format)
• Health Canada Releases Draft Guidance on Subsequent Entry Biologics
• User Fees in Canada: A Review of Current and Proposed Fees (PDF Format)
• Health Canada Releases Final Guidance Document on NOC Regulations
• Amendments to the Patented Medicines (Notice of Compliance) Regulations and the Data Protection Provisions of the Food and Drug Regulations in Force
• Direct-to-Consumer Drug Advertising in Canada (PDF Format)
• The Globalization of the Regulatory Affairs Profession (PDF Format)
• Inspection by the HPFBI – Will it be Predictable and Uniform? (PDF Format)
• Bill C-9: The Complaints of the Generic Drug Manufacturers and the Perspective of Developing Countries
• New Canadian Food Labeling Regulations* (PDF Format)
  * With permission from FDLI
• Drugs for Neglected Diseases Initiative Focuses on Developing New Treatments for Overlooked Diseases
• International Trade, Generic Drugs and the Developing World
• Regulation of Natural Health Products in Canada* (PDF Format)
  * With permission from FDLI
• Regulations Governing Medical Devices in Canada